EBITDA Margin % is calculated as EBITDA divided by its Revenue. Perpetua Medical AB's EBITDA for the
three
months ended in Mar. 2026 was $-0.15 Mil. Perpetua Medical AB's Revenue for the
three
months ended in Mar. 2026 was $0.54 Mil. Therefore, Perpetua Medical AB's EBITDA margin for the quarter that ended in Mar. 2026 was -28.60%.
Perpetua Medical AB (OTCPK:PPTMF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Perpetua Medical AB EBITDA Margin % Related Terms
Perpetua Medical AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Perpetua Medical AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PPTMF vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Perpetua Medical AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perpetua Medical AB EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perpetua Medical AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Perpetua Medical AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perpetua Medical AB (PPTMF) has a EBITDA Margin % of -28.60% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Perpetua Medical AB and its competitors. According to the industry distribution chart, Perpetua Medical AB ranks #160 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 19.6%.
Is Perpetua Medical AB's EBITDA Margin % too high?
Perpetua Medical AB's current EBITDA Margin % is -28.60%. Based on the distribution chart, Perpetua Medical AB ranks #160 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Perpetua Medical AB has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Perpetua Medical AB's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Perpetua Medical AB ranks #160 out of 816 companies for EBITDA Margin %. This places Perpetua Medical AB in the top 20% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Perpetua Medical AB and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perpetua Medical AB's current EBITDA Margin % is -28.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perpetua Medical AB stock overvalued right now?
Perpetua Medical AB (PPTMF) has a current EBITDA Margin % of -28.60%. The stock's GF Value™ is $1.24, compared to a current price of $1.08 — trading 13% below its estimated fair value. The current EBITDA Margin % is -28.60%. Perpetua Medical AB's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Perpetua Medical AB (PPTMF), the current EBITDA Margin % is -28.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perpetua Medical AB (PPTMF) Overvalued in 2026?
Based on GuruFocus' analysis, Perpetua Medical AB stock appears to be undervalued.
The current stock price of $1.08 is trading 13% below its estimated GF Value™ of $1.24.
Key valuation signals for PPTMF:
EBITDA Margin %: -28.60%
GF Value™: $1.24 vs. price of $1.08 (13% below fair value)
No single metric tells the full story. See the PPTMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
57GF Score
Get the complete analysis for PPTMF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PPTMF has been successfully added to your 
